Risky vaccine for rare meningitis B now being pushed by the CDC
Last year, officials from the Centers for Disease Control and Prevention stood before the American public and lied to our faces.
They claimed there was an outbreak of meningitis B, a potentially deadly swelling of the brain and spinal cord. Our government even rushed two new vaccines to market and the CDC has just recommended the shots for millions of teens and young adults between the ages of 16 and 23.
But before you ask your child or grandchild to roll up his sleeve, there are a few things you ought to know.
The meningitis B outbreak is a fairy tale, invented from thin air. The disease is so rare you have a better chance of being struck by lightning than catching it.
And now two of the world’s largest drug companies stand to make billions off these shots. Shots that have barely been tested, may not work, and could even attack your brain.
Only about 110 Americans get meningitis B a year. If you put all those people on a Boeing 747 airplane, they wouldn’t fill 20 percent of the seats.
But that didn’t stop the CDC from declaring an outright plague had broken out last year when we saw seven new cases at two college campuses.
The media hysterically rushed in with stories about how we needed new vaccines to protect our kids. And that was the start of a billion-dollar swindle that’s going to put millions of young people at risk.
The FDA has now approved the meningitis B vaccines Bexsero from Novartis and Trumenba from Pfizer — two of the largest drug companies in the world. With the CDC recommending the shots, these drug giants stand to make a fortune. And if the vaccines ever make the official CDC vaccination schedule, millions of Californian teens would now be forced to get them under new state law.
And such a wide distribution of the meningitis B vaccines doesn’t sit too well with Temple University’s Dr. Thomas Fekete, one of the top infectious disease experts in the world.
He points out that meningitis B is so rare that the vaccine practically can’t be worth the risk. Your chances of getting meningitis B are so remote that if even one person out of 10,000 has an adverse reaction, it’ll mean the vaccines are doing more harm than good.
But you can bet that Bexero and Trumenba are going to cause a lot more trouble than that.
You see, both vaccines were rushed through the FDA’s “breakthrough therapy” program with limited testing — something Dr. Fekete warned was a mistake. In fact, neither the FDA, CDC, Pfizer, nor Novartis has any idea how long the vaccines’ protection even lasts.
But what we do know is that the meningitis B vaccines can head straight to your brain and unleash a lifetime of damage. The vaccines have something called a “sugar sequence” that closely matches what we see in our brains.
And that means that the antibodies from the shot can attack your brain and nerves, triggering an autoimmune disease you could have for life. And even if you’re lucky enough to survive that, the vaccines have been shown to cause vomiting, fevers, and serious diarrhea.
That’s going to be a big problem in some places around the world, like Scotland, that are getting ready to force these unproven vaccines on innocent babies. And America could very well be next.
The meningitis B vaccines are nothing more than our government and Big Pharma doing what they do best — launching a fear campaign meant to make us line up for risky shots to make sure there is no risk to their bottom line.
Sources:
“Vaccine against meningitis B gets a boost from CDC” Patti Neighmond, June 29, 2015, NPR, npr.org
“Q&A: Meningitis B vaccine” BBC, June 20, 2015, bbc.com
“College meningitis B outbreaks and a new vaccine” Karie Youngdahl, The history of vaccines blog, historyofvaccines.org
